Remo-Zen 100mg Tablet

Introduction

Remo-Zen is a prescription medication that contains the active ingredient Remogliflozin Etabonate. It is available in tablet form and is commonly used to manage blood sugar levels in adults with type 2 diabetes.

Uses

Remo-Zen is primarily prescribed to help control blood sugar levels in adults with type 2 diabetes. It is used as an adjunct to diet and exercise to improve glycemic control. By inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, Remo-Zen helps to reduce the reabsorption of glucose and increase its excretion in the urine. This mechanism of action can help lower blood sugar levels in individuals with type 2 diabetes.

Dosage and Administration

The recommended dosage of Remo-Zen may vary depending on individual factors such as the patient’s overall health and response to treatment. Follow your healthcare provider’s instructions carefully. Typically, the initial dose is 100 mg taken orally once daily, with or without food. Your healthcare provider may adjust the dose as needed.

Take Remo-Zen regularly to achieve the desired effect. If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

Mechanism of Action

Remo-Zen works by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the urine back into the bloodstream. By blocking this protein, Remo-Zen increases the excretion of glucose in the urine, thereby reducing blood sugar levels. This mechanism of action helps to improve glycemic control in individuals with type 2 diabetes.

Side Effects

Common side effects may include urinary tract infections, increased urination, genital infections, and thirst. These side effects are usually mild and transient.

In some cases, Remo-Zen may cause more serious side effects. These can include ketoacidosis (increased ketone levels in the blood), hypoglycemia (low blood sugar), and allergic reactions. If you experience any of these serious side effects, seek medical attention immediately.

Drug Interactions

Remo-Zen may interact with other medications, so inform your healthcare provider about all the medications you are currently taking. Some medications that may interact with Remo-Zen include diuretics, insulin or insulin secretagogues (e.g., sulfonylureas), and medications that can increase the risk of hypoglycemia. Your healthcare provider will consider these potential interactions when prescribing Remo-Zen.

Precautions

Before taking Remo-Zen, inform your healthcare provider about any medical conditions you have, including kidney problems, liver problems, or a history of urinary tract infections. Additionally, inform your healthcare provider about all medications, vitamins, and herbal supplements you are taking, as they may interact with Remo-Zen.

Remo-Zen is contraindicated in individuals with a known hypersensitivity to Remogliflozin Etabonate or any of the other ingredients in the tablet.

Storage

Patient Tips

• Take Remo-Zen as prescribed by your healthcare provider and follow their instructions regarding diet and exercise.
• Monitor your blood sugar levels regularly and report any significant changes to your healthcare provider.
• Stay hydrated and drink plenty of fluids while taking Remo-Zen.
• Be aware of the signs and symptoms of hypoglycemia (low blood sugar) and ketoacidosis (increased ketone levels in the blood), and seek medical attention if you experience them.
• Inform your healthcare provider about any other medications or supplements you are taking to avoid potential drug interactions.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Lotemax: Uses, Directions, Side Effects, Warnings Consumer Information (Drugs.com) [Accessed 18 Jun. 2024] (online) Available at:
• Markham A. Remogliflozin Etabonate: First Global Approval. Drugs. 2019 Jul;79(10):1157-1161. doi: 10.1007/s40265-019-01150-9. [Accessed 24 Jun. 2024] Available at:
• Eysuvis Dosage Guide (Drugs.com) [Accessed 15 Jun. 2024] (online) Available at:
• Lotemax Eye Gel Dosage Guide (Drugs.com) [Accessed 26 Jun. 2024] (online) Available at: